Welcome to Mediscript: Providing innovation, imagination, inspiration and integrity
   

18th Annual Resistance and Antiviral Therapy Meeting
NEW FRONTIERS IN VIROLOGY: SCIENTIFIC PROGRESS THAT CHANGES CLINICAL CARE

Thursday 18 September 2014, Royal College of Physicians, London

Resistance 2014

Please click here to download the Final Programme.

 

 

Conference Report

The 18th Annual Resistance and Antiviral Therapy Meeting was held at the Royal College of Physicians in London on Thursday 18 September 2014. Our international speakers included Professor Jeff Johnson, Professor Massimo Levrero, Dr Janke Schinkel and Dr Martin Tolstrup.

Delegate feedback reported that the programme contained highly qualified speakers who provided updates on the very latest information/research. In total over 100 delegates registered for the meeting. This number included 5 student scholarship winners and 1 community registration place.



Presentations

Introduction
Professor Anna Maria Geretti, Institute of Infection and Global Health, University of Liverpool

Session 1: The future of HIV care
Chair: Professor Anna Maria Geretti, Institute of Infection and Global Health, University of Liverpool

Injectable ART: a SWAT analysis
Dr Anton Pozniak, Chelsea and Westminster Hospital, London

Scientific evidence that drives clinical practice: five key papers from 2014
Dr Marta Boffito, Chelsea and Westminster Hospital, London

Session 2: Curative strategies
Chair: Professor Jonathan Weber, Imperial College London

The promise of a functional HIV cure: fact or fiction?
Dr Martin Tolstrup, Aarhus University Hospital, Denmark

Can we eradicate chronic hepatitis B infection?
Professor Massimo Levrero, Sapienza University, Rome, Italy

Is NS5a a suitable target to cure hepatitis C infection?
Professor Matthias Götte, University of Alberta, Edmonton, Canada

Keynote lecture
Chair: Professor David Dunn, MRC Clinical Trials Unit, London

Advances in the management of HTLV infection
Professor Graham Taylor, Imperial College London

Session 3: Work in progress emerging findings from UK-based studies
Chairs: Professor William Irving, University of Nottingham
Professor Andrew Leigh Brown, University of Edinburgh

The CNS has an HIV reservoir (the PARTITION study)
Dr Sam Nightingale, University of Liverpool

Risk of transmission among discordant partners (the PARTNER study)
Dr Alison Rodger, University College London

Evolving HIV quasispecies in early HIV infection (the DEEP-HIV study)
Mr John Ambrose, University College London

HCV genomes in disease and treatment (the STOP-HCV study)
Dr Emma Thomson, University of Glasgow

Are nano-antiretrovirals efficient inhibitors of HIV replication in vitro? (the NANO-ARV study)
Ms Stacey King, University of Liverpool

Session 4: Undertaking HIV drug resistance
Chairs: Professor Saye Khoo, University of Liverpool
Dr Colette Smith, University College London Medical School

Clinical use of deep sequencing for the detection of hepatitis C and HIV drug-resistance
Dr Janke Schinkel, Academic Medical Centre, Amsterdam, The Netherlands

Tracking the origin of HIV-1 drug-resistance strains
Professor Jeff Johnson, CDC, Atlanta, USA

Close
Professor Anna Maria Geretti, Institute of Infection and Global Health, University of Liverpool
Professor Jonathan Weber, Imperial College London

Continuing Professional Development (CPD)

Medical staff in career-grade posts who are enrolled with one of the Federation of Royal Colleges for Continuing Professional Development can receive CPD credits at the rate of one CPD credit per hour (exclusive of travel, refreshments or social activities). The conference has been allocated 6 CPD credits with the unique reference code: 91254. Certificates for attendance were supplied in the conference pack that was handed to you at the registration desk.